[Form 3] Mobileye Global Inc. Initial Statement of Beneficial Ownership

Rhea-AI Filing Summary

Mobileye Global Inc. (MBLY) Form 3 filed for Chandrasekaran Nagasubramaniyan, reporting an initial statement of beneficial ownership arising from an 08/25/2025 event. The filer is identified as a Director and the filing indicates no securities are beneficially owned at the time of this report. The form was submitted by one reporting person and signed by an attorney-in-fact on 09/04/2025. Exhibit 24 (Power of Attorney) is attached.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Chandrasekaran Nagasubramaniyan

(Last) (First) (Middle)

C/O MOBILEYE B.V.

HAR HOTZVIM, 1 SHLOMO MOMO HALEVI STREET

(Street)

JERUSALEM L3 9777015

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
08/25/2025

3. Issuer Name and Ticker or Trading Symbol
Mobileye Global Inc. [ MBLY ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Liz Cohen-Yerushalmi, Attorney-in-Fact	09/04/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does Mobileye (MBLY) Form 3 filed by Chandrasekaran Nagasubramaniyan report?

The Form 3 reports that Chandrasekaran Nagasubramaniyan, a Director, has filed an initial beneficial ownership statement and no securities are beneficially owned as of the filing.

What is the effective date of the ownership event on the MBLY Form 3?

The date of the event requiring the statement is 08/25/2025.

Who signed the Form 3 for MBLY and when was it signed?

The Form 3 was signed by Liz Cohen-Yerushalmi, Attorney-in-Fact on 09/04/2025.

Does the MBLY Form 3 indicate joint filing or multiple reporting persons?

No. The filing certifies it is a Form filed by one reporting person.

Is there any derivative or non-derivative security ownership listed on the MBLY Form 3?

No. The form explicitly states no securities are beneficially owned, and no entries appear in Table I or Table II.